{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:44Z","timestamp":1790713184186,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2019.06.028","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T04:58:34Z","timestamp":1561093114000},"page":"128-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy"],"prefix":"10.1016","volume":"47","author":[{"given":"Mohammad","family":"Alyami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Bonnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Laplace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Passot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejso.2019.06.028_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2019.06.028_bib2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2019.06.028_bib3","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jamaoncol.2017.0515","article-title":"Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial","volume":"3","author":"Al-Batran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2019.06.028_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","article-title":"Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.028_bib5","first-page":"59","article-title":"Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management","volume":"52","author":"Chua","year":"2009","journal-title":"Canadian journal of surgery Journal canadien de chirurgie"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.028_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2019.06.028_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/bjs.10521","article-title":"Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis","volume":"104","author":"Grass","year":"2017","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.ejso.2019.06.028_bib8","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.21873\/anticanres.13062","article-title":"No renal toxicity after repeated treatment with pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with unresectable peritoneal metastasis","volume":"38","author":"Larbre","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2019.06.028_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2019.06.028_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","article-title":"Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study","volume":"44","author":"Nowacki","year":"2018","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"11","key":"10.1016\/j.ejso.2019.06.028_bib11","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.ejso.2017.09.010","article-title":"Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis","volume":"43","author":"Alyami","year":"2017","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"20","key":"10.1016\/j.ejso.2019.06.028_bib12","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"36","key":"10.1016\/j.ejso.2019.06.028_bib13","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"6","key":"10.1016\/j.ejso.2019.06.028_bib14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Goere","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2019.06.028_bib15","first-page":"1","article-title":"Long-term survival in patients with epithelial ovarian cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","author":"Le Saux","year":"2018","journal-title":"Int J Hyperth : The Off. J. European Soc. Hypertherm. Oncol. North American Hyperthermia Group"},{"issue":"6","key":"10.1016\/j.ejso.2019.06.028_bib16","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.06.028_bib17","first-page":"359","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"vol. 82","author":"Jacquet","year":"1996"},{"issue":"6","key":"10.1016\/j.ejso.2019.06.028_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","article-title":"A\u00a0new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application","volume":"42","author":"Villeneuve","year":"2016","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"11","key":"10.1016\/j.ejso.2019.06.028_bib19","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1245\/s10434-013-3039-x","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects","volume":"20","author":"Solass","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2019.06.028_bib20","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejso.2017.03.019","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy - practical aspects","volume":"43","author":"Hubner","year":"2017","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.028_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s11605-017-3565-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedure for non-resectable peritoneal carcinomatosis (with video)","volume":"22","author":"Cazauran","year":"2018","journal-title":"J\u00a0Gastrointest Surg : official journal of the Society for Surgery of the Alimentary Tract"},{"issue":"9","key":"10.1016\/j.ejso.2019.06.028_bib22","first-page":"3748","article-title":"The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe","volume":"46","author":"Nowacki","year":"2018","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.ejso.2019.06.028_bib23","first-page":"247","article-title":"Peritonectomy procedures","volume":"134","author":"Sugarbaker","year":"2007","journal-title":"Cancer Treat Res"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.028_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.028_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0091270009360980","article-title":"Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure","volume":"51","author":"Cotte","year":"2011","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.ejso.2019.06.028_bib26","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1245\/s10434-011-1651-1","article-title":"Closed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study","volume":"18","author":"Cotte","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2019.06.028_bib27","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J","article-title":"Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis","volume":"88","author":"Beaujard","year":"2000","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2019.06.028_bib28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","article-title":"The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Prada-Villaverde","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2019.06.028_bib29","first-page":"E113","article-title":"Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C","volume":"91","author":"Sayag-Beaujard","year":"2004","journal-title":"Bull Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2019.06.028_bib30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.028_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","author":"Tempfer","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2019.06.028_bib32","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtroder","year":"2016","journal-title":"Colorectal Dis : the official journal of the Association of Coloproctology of Great Britain and Ireland"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.028_bib33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis","volume":"20","author":"Nadiradze","year":"2016","journal-title":"J\u00a0Gastrointest Surg : official journal of the Society for Surgery of the Alimentary Tract"},{"issue":"2","key":"10.1016\/j.ejso.2019.06.028_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Bibeau F Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura and Peritoneum"},{"issue":"7","key":"10.1016\/j.ejso.2019.06.028_bib35","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jso.24248","article-title":"What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures","volume":"113","author":"Passot","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2019.06.028_bib36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/02656736.2017.1367846","article-title":"Ninety-day post-operative morbidity and mortality using the National Cancer Institute\u2019s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"34","author":"Alyami","year":"2018","journal-title":"Int J Hyperthermia"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319305220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319305220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:07:39Z","timestamp":1755274059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319305220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0748798319305220"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.06.028","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}